Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.

AUTOR(ES)

Mauriello, J A

RESUMO

BACKGROUND: A retrospective review of 239 patients with benign essential blepharospasm and Meige syndrome was performed in order to determine patients' long term treatment preferences. METHODS: Of 239 patients evaluated, 228 received local injections of botulinum toxin, type A, into the eyelid and facial musculature over 11 years. RESULTS: Of 228 patients, 202 (72.1%) were still treated with botulinum toxin, type A. Eighteen patients (6.9%) no longer received botulinum toxin injections and sought no other treatment. Five patients (2.2%) had apparent remission of their disease after injection. Three patients (1.3%) ultimately obtained relief from orbicularis muscle extirpative surgery and required no additional treatment. Two of the 11 patients (4.6%) who chose not to receive botulinum toxin injections were successfully treated with other modalities: psychotherapy (one patient) and oral haloperidol (one patient). CONCLUSION: While botulinum toxin is the most highly effective treatment for benign essential blepharospasm and Meige syndrome over a long period of time, adjunctive oral drug therapy, including minor tranquillisers as well as eyelid surgery, may augment its effectiveness.

Documentos Relacionados

• Prognosis of rheumatoid arthritis. A prospective survey over 11 years.
• Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.
• Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years.
• Lung function, atopy, specific hypersensitivity, and smoking of workers in the enzyme detergent industry over 11 years.
• Chronic bronchitis--measurements and observations over 10 years.